Cardiovascular

Latest News

FDA headquarters | Image Credit: Grandbrothers - stock.adobe.com
FDA Approves Acoramidis for ATTR-CM

November 25th 2024

With approval, acoramaidis (Attruby; BridgeBio Pharma) becomes the first agent with a label specifying near-complete stabilization of transthyretin (TTR).

Cardiovascular health | Image Credit: BillionPhotos.com - stock.adobe.com
Unfavorable Health-Related Social Needs Associated With Lower Cardiovascular Health Scores

November 25th 2024

Heart examination | Image credit: Ngampol - stock.adobe.com
Elevated Stress Hyperglycemia Ratio Linked to Higher All-Cause Mortality After Cardiovascular Events

November 20th 2024

Smoking health risk | Image credit: sorapop - stock.adobe.com
How Smoking Cessation Affects Cardiovascular Disease Risk Over Time

November 15th 2024

Stressed female employee | Image Credit: Charlie's - stock.adobe.com
Work-Related Stress Linked to Poor Cardiovascular Health

November 6th 2024

Advancements in Population Health Strategies for Cardiovascular Risk Management

Experts discuss how lipoproteins drive atherosclerotic heart disease, review the different guidelines and recommendations on Lp(a) testing, and insights from clinical trials.

Hands holding a heart with a heartbeat on it and the words AJMC Insights
Continuing Medical Education
View All
December 3rd 2024

Evidence-Based Guidelines Point to Leap in Care for Hypertrophic Cardiomyopathy

December 11, 2024 | 1:00 PM & 8:00 PM ET
December 3rd 2024

Advances and Best Practices for Managed Care Pharmacists in the Treatment of Heart Failure with Preserved Ejection Fraction

1.0 Credits / Cardiology
December 3rd 2024

Exploring Transthyretin-Mediated Amyloidosis and Its Phenotypes: A Comprehensive Approach to Patient Treatment

1.5 Credits / Cardiology, Neurology, Rare Diseases
December 3rd 2024

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology

More News

A Historic View on CV Outcomes in Diabetes
May 15th 2017

A Historic View on CV Outcomes in Diabetes

Shared Decision-Making in Diabetes
May 15th 2017

Shared Decision-Making in Diabetes

Cost-Effectiveness and Coverage Decisions in Diabetes
May 15th 2017

Cost-Effectiveness and Coverage Decisions in Diabetes

Big Data Analysis and Clinical Decision Making in Diabetes
May 15th 2017

Big Data Analysis and Clinical Decision Making in Diabetes

Designing Better Cardiovascular Outcomes Trials in Diabetes
May 15th 2017

Designing Better Cardiovascular Outcomes Trials in Diabetes

Big Data and CVD Benefits of Anti-Diabetes Medications
May 15th 2017

Big Data and CVD Benefits of Anti-Diabetes Medications

Understanding Heart Failure in Diabetes
May 15th 2017

Understanding Heart Failure in Diabetes

Cardiovascular Outcomes Trials With Anti-Diabetes Medications
May 15th 2017

Cardiovascular Outcomes Trials With Anti-Diabetes Medications

SGLT2 Inhibition and CVD Outcomes in Type 2 Diabetes
May 15th 2017

SGLT2 Inhibition and CVD Outcomes in Type 2 Diabetes

Cardiovascular Outcomes With GLP-1 Receptor Agonists in Type 2 Diabetes
May 15th 2017

Cardiovascular Outcomes With GLP-1 Receptor Agonists in Type 2 Diabetes

Impact of the EMPA-REG Study in Type 2 Diabetes
May 15th 2017

Impact of the EMPA-REG Study in Type 2 Diabetes

Site Logo
May 10th 2017

Smoking Cessation Treatments Do Not Increase Risks in Patients With COPD

AJMC Staff
Getting smokers to quit smoking sometimes requires medical intervention, such as varenicline and bupropion; however, there have been concerns about the safety of these smoking cessation treatments in smokers with chronic obstructive pulmonary disease.
Site Logo
April 20th 2017

Medication Burden in Patients With Acute Coronary Syndromes

Eric A. Wright, PharmD, MPH Steven R. Steinhubl, MD JB Jones, PhD, MBA Pinky Barua, MSc, MBA Xiaowei Yan, PhD Ryan Van Loan, BA Glenda Frederick, BA Durgesh Bhandary, MS David Cobden, Ph
Patients endure heavy medication complexity following hospital discharge for acute coronary syndrome.
Dr Janet Wright on Cardiologists' Role in Public Health and Prevention Efforts
April 15th 2017

Dr Janet Wright on Cardiologists' Role in Public Health and Prevention Efforts

The Million Hearts initiative, with its goal of preventing a million cardiovascular events in 5 years, requires sustained efforts by cardiologists in conjunction with public health experts to achieve success, explained Janet Wright, MD, FACC, the program’s executive director.
Unmet Needs in Cholesterol Management
April 13th 2017

Unmet Needs in Cholesterol Management

The Future of Lipid Management
April 13th 2017

The Future of Lipid Management

Cholesterol Management and Long-Term Cardiovascular Disease Prevention
April 13th 2017

Cholesterol Management and Long-Term Cardiovascular Disease Prevention

PCSK9 Inhibitors: Cost Concerns and Access
April 13th 2017

PCSK9 Inhibitors: Cost Concerns and Access

Clinical Experience With PCSK9 Inhibitors
April 13th 2017

Clinical Experience With PCSK9 Inhibitors

Alternate Mechanisms of Action for Cholesterol Management
April 13th 2017

Alternate Mechanisms of Action for Cholesterol Management

Candidacy for Later-Line Cholesterol-Lowering Therapies
April 13th 2017

Candidacy for Later-Line Cholesterol-Lowering Therapies

Management of High-Risk Populations With Hyperlipidemia
April 13th 2017

Management of High-Risk Populations With Hyperlipidemia

Efficacy and Safety of PCSK9 Inhibitors
April 13th 2017

Efficacy and Safety of PCSK9 Inhibitors

Lipid Management: Coverage Criteria vs FDA Labeling
April 13th 2017

Lipid Management: Coverage Criteria vs FDA Labeling

Coverage of Statins/Nonstatins in Lipid Management
April 13th 2017

Coverage of Statins/Nonstatins in Lipid Management

Cholesterol Goals in Primary Cardiovascular Disease Prevention
April 13th 2017

Cholesterol Goals in Primary Cardiovascular Disease Prevention

Early Detection of Risk and Familial Hypercholesterolemia
April 13th 2017

Early Detection of Risk and Familial Hypercholesterolemia

Managed Care Decision Making in CVD and Lipid Control
April 13th 2017

Managed Care Decision Making in CVD and Lipid Control

Current CVD Prevention and Management Challenges
April 13th 2017

Current CVD Prevention and Management Challenges

Dr Janet Wright Discusses How Million Hearts Will Leverage Partnerships for Success
April 6th 2017

Dr Janet Wright Discusses How Million Hearts Will Leverage Partnerships for Success

The Million Hearts initiative, which aims to prevent a million cardiovascular events in a 5-year period, will focus on utilizing its partnerships with health systems and employers as it embarks upon its second phase, according to Janet Wright, MD, FACC, the program’s executive director.
<1
...
111213141516171819
...
22>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo